[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$flQL-jCEGuj-VF3jh6yKx4ksuVkNqJ1qZuIn2e9vwnLA":3},{"answer":4,"createTime":5,"id":6,"options":7,"origin":10,"question":16,"related":17,"source":23,"type":24},[],"2026-04-07 21:12:46",1087503649,[8,9],"对","错",{"courseId":11,"courseImg":12,"courseName":13,"workId":14,"workName":15},"1000068648","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002Ffd8cd4ffaa0c7b282a280f65c2ed3f0e.jpg","肿瘤学","63878634","第三章单元测试","对接受新辅助化疗后临床完全缓解的乳腺癌患者,可不接受后续的手术及术后辅助治疗.( )",[18,25,28,33,43],{"answer":19,"createTime":5,"id":20,"options":21,"question":22,"source":23,"type":24},[],1087503646,[8,9],"对HR+、HER2-乳腺癌,腋窝淋巴结转移≥4个或腋窝淋巴结转移1-3个但同时伴有其他高危因素的患者属于高复发风险的患者,推荐选用AC-T治疗方案.( )","v2",3,{"answer":26,"createTime":5,"id":6,"options":27,"question":16,"source":23,"type":24},[],[8,9],{"answer":29,"createTime":5,"id":30,"options":31,"question":32,"source":23,"type":24},[],1087503655,[8,9],"对于乳腺癌根治性切除后患者,T3-4、腋窝淋巴结阳性的患者需要行放疗,而前哨淋巴结阳性及未行腋窝清扫的患者不需行放疗.( )",{"answer":34,"createTime":5,"id":35,"options":36,"question":41,"source":23,"type":42},[],1087503662,[37,38,39,40],"腋窝淋巴结≥4个阳性","腋窝淋巴结1~3个阳性但同时伴有组织学分级为III级、T ≥5cm、 Ki67 ≥20%等危险因素之一者","初始治疗推荐AI治疗5年联合阿贝西利治疗2年","初始治疗可选择AI治疗5年","对于绝经后的高复发风险乳腺癌患者,以下哪些描述是正确的( )",1,{"answer":44,"createTime":5,"id":45,"options":46,"question":51,"source":23,"type":52},[],1087503665,[47,48,49,50],"来曲唑","阿那曲唑","他莫昔芬","依西美坦","对乳腺癌内分泌治疗药物,以下不属于芳香化酶抑制剂的是( )",0]